Novartis Investigator Site

Ste-Foy

0 studies enrolling now · 3 studies all time

What they study most

Asthma, COPD, Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive

Studies at this site

• 1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma — Completed
• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed